Applications of 2-Bromo-1-(2,3-Dihydro-1,4-Benzodioxin-6-Yl)Ethan-1-One in Industrial Manufacturing

As a direct manufacturer, we supply 2-Bromo-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one to downstream users who apply this specialty intermediate in precisely controlled industrial syntheses. We address application needs in pharmaceutical, fine chemical, and advanced material production—focusing on those sectors with established, compliant, and scalable demand.

1. Pharmaceutical Intermediates for Benzodioxin Derivative APIs

Downstream pharmaceutical producers utilize this compound as a key building block in multistep API syntheses, most notably for molecules with benzodioxin or related heterocyclic backbones. Its brominated ketone function provides site-selective reactivity for nucleophilic substitution or condensation, critical in assembling anti-infective, CNS active, or cardiovascular compounds. Our customers integrate this raw material at the functionalization stage, where consistency and trace impurity control directly impact drug substance quality.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• 21 CFR Part 211 (US cGMP for Finished Pharmaceuticals)
• EDQM CEP/CoS for use in APIs sold within the EU
• USP <1078> Good Manufacturing Practices for Bulk Pharmaceutical Excipients

Typical usage ratio

• Applied at 0.8–1.2 molar equivalents to the intended active core; final ratio determined by route yield and contaminant profile optimization.

Downstream process integration

• Introduced in the early-to-intermediate synthesis steps for nucleophilic aromatic substitution or Grignard-type transformations, typically under inert atmosphere and monitored by in-process HPLC or GC.

Final product types

• Benzodioxin-containing APIs for CNS, antibacterial, and antiviral indications
• Advanced pharmaceutical intermediates for regulatory filing batches

2. Fine Chemical Manufacture of Agrochemical Precursors

Agrochemical manufacturers source the material for use in constructing advanced intermediates crucial for fungicide and insecticide active development. Its brominated moiety facilitates regioselective introduction of biologically active groups, supporting SAR (structure–activity relationship) lead optimization. High purity guarantees minimal byproduct carryover through multi-step syntheses, which affect final formulation toxicology.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• ISO 9001:2015 for Quality Management Systems
• OECD Principles of Good Laboratory Practice (GLP) for pre-formulation research
• REACH (EC) No.1907/2006 (for EU market entry)

Typical usage ratio

• Typically charged at 0.7–1.1 equivalents relative to aryl core substrate; ratios fine-tuned based on route development and waste minimization studies.

Downstream process integration

• Employed during early-stage arylation or halogen exchange; introduced via controlled addition in sealed reactors with continuous process monitoring for exotherms and endpoint determination by HPLC.

Final product types

• Advanced agrochemical intermediates for use in triazole, strobilurin, and neonicotinoid product classes
• Reference standards for bioactivity screens

3. Synthesis of Electronic & Functional Materials

Producers in the electronic materials segment integrate this intermediate in the customized synthesis of organic functional molecules, including OLED emitter precursors and specialty dye components. Its capacity for precise substitution on oxygenated aromatic systems ensures consistent end-use performance in optoelectronic assemblies, where purity and batch reproducibility prevent device-level failures.

Industry compliance standards

• ISO 9001:2015 Quality Management for electronic grade raw materials
• RoHS Directive 2011/65/EU compliance for restricted substance content
• IEC 60068 environmental testing protocols for material qualification
• REACH registration for electronic industry chemicals in the EU

Typical usage ratio

• Formulation at 0.9–1.0 molar equivalents, with strict stoichiometry controlled by in-line NMR or MS analysis due to sensitivity of final optical properties to trace residue levels.

Downstream process integration

• Dosed as the aromatic bromide reactant during C–C or C–N cross-couplings, used in prepolymer synthesis for emitting layers or as a synthon for functionalized dye intermediates; integrated with real-time handling under nitrogen and microfiltration.

Final product types

• OLED (organic light-emitting diode) small molecule intermediates
• Functionalized colorants and laser dyes for imaging or sensor devices

4. Custom Synthesis Services for Research & Pharmaceutical Pilot Production

CMOs and research laboratories order this intermediate as a controlled-stage precursor for rapid synthesis route prototyping and scale transition runs. Its clean halogenation profile and controlled particle size facilitate quick adaptation to micro-scale, kilo-lab, and GMP-pilot environments, where reliable impurities data simplify regulatory documentation and risk assessments.

Industry compliance standards

• ISO 17025 Accredited Analytical Testing
• ICH Q11 Development and Manufacture of Drug Substances
• US FDA QSR (21 CFR Part 820) for medical device-related synthesis
• Client internal SOPs for material traceability and lot control

Typical usage ratio

• Scaled between 1.0–1.3 equivalents, with loading customized for each pilot route to match target output, impurity studies, and feasibility evaluation protocols.

Downstream process integration

• Introduced in modular synthesis modules, added to batch reactors or continuous flow equipment based on process development stage, with on-line PAT (Process Analytical Technology) tools for endpoint validation and data logging.

Final product types

• Pilot-scale API intermediates for process validation
• Reference compound libraries for SAR and screening
• Custom chemical entities for preclinical studies

5. Specialty Fine Chemical Synthesis for Advanced Polymer Additives

Specialty polymer and coating manufacturers apply this intermediate as an essential synthon in the synthesis of benzodioxin-based monomers or functional side chains, supporting materials used in high-performance coatings, adhesives, and engineered plastics. Its structure offers compatibility with radical and nucleophilic polymerization, producing additives that modify mechanical or dielectric properties in the final compound.

Industry compliance standards

• ISO 14001:2015 for Environmental Management Systems in chemical processing
• UL 94 flammability standards (for electrical polymer applications)
• ROHS/REACH for restricted substance listing
• ASTM D2565 for UV stability in polymer materials

Typical usage ratio

• Usually 0.5–1.0 weight percent for additive synthesis; ratio adjusted according to polymer chain length requirements and final surface energy specifications.

Downstream process integration

• Fed into bulk polymerization or functionalization reactors during the additive modification stage, with quality checkpoints for degree of conversion and residual bromine by spectroscopic analysis.

Final product types

• High-performance plasticizers and chain extenders
• Resilient polymer coatings for medical and electronic components
• Crosslinking agents in advanced adhesive formulations